Of Note

Farzan Lab HIV Study Ranks in Discover’s Top Stories of 2015

A study led by Michael Farzan, professor at The Scripps Research Institute (TSRI) Florida campus, is ranked among Discover magazine’s top 100 stories of 2015. The study, published in the journal Nature, described the Farzan lab’s creation of a drug candidate that neutralizes a wide variety of HIV virus strains and provides vaccine-like protection in animal models.

Featured in Discover’s January/February 2016 issue, the ranking represents the best in science from the past year, according to the editors.

For further information on the study, see the News&Views article “Scientists Announce Anti-HIV Agent So Powerful It Can Work in a Vaccine.” To see the complete Discover top 100 stories of 2015, visit the publication’s website to view the entry on the Farzan study, see “Technique Blocks HIV Invasion.”

Ron Davis Elected AAAS Council Delegate

Ron Davis, professor and chair of TSRI’s Department of Neuroscience on the Florida campus, has been elected a council delegate from the Section on Neuroscience of the American Association for the Advancement of Science (AAAS).

Davis’s responsibilities during his three-year term, which begins February 2016, include participating in AAAS organizational, electoral, procedural and policy matters.

Founded in 1848 and based in New York City, the 120,000-member AAAS is an international nonprofit organization dedicated to advancing science.

Send comments to: mikaono[at]scripps.edu

Professor Michael Farzan’s advance against HIV is ranked among Discover magazine’s top stories of 2015. (Photo by James McEntee.)

SEARCH NEWS & VIEWS

Team Finds Unique Anti-Diabetes Compound Using Powerful New Drug-Discovery Method

Scientists Create 'Fingerprints' for Major Drug Development Targets

Researchers Show How Drug Molecules Regulate a Medically Important Protein

Making Scrap Pay

Of Note

Farzan Lab HIV Study Ranks in Discover’s Top Stories of 2015

Ron Davis Elected AAAS Council Delegate